CMS Considers Coverage For GE’s Risk-Predictor Tool For Sudden Cardiac Death

The Medicare agency says it is reconsidering a 2008 national noncoverage policy for GE Healthcare’s microvolt T-Wave alternans testing tool for evaluating risk of sudden cardiac death, and the potential need for an ICD. An alternative MTWA technique is already covered, but the company that makes that product is going out of business.

CMS is taking another look at GE Healthcare’s ambulatory electrocardiogram analysis tool that could assess patients’ need for a primary-prevention implantable cardioverter defibrillator.

In 2008, the Medicare agency issued a national noncoverage policy for GE’s method for measuring so-called microvolt T-Wave alternans to...

More from Policy & Regulation

More from Medtech Insight